Global New-Born Screening Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • New-Born Screening market report explains the definition, types, applications, major countries, and major players of the New-Born Screening market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Waters

    • Natus Medical

    • Bio-Rad Laboratories

    • Trivitron Healthcare

    • Perkinelmer

    • AB Sciex

    • GE Healthcare

    • Covidien

    • Masimo

    • Agilent Technologies

    By Type:

    • Tandem Mass Spectrometry

    • Pulse Oximetry Screening Technology

    • DNA-Based Assays

    • Hearing Screen Technology

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Nursing Homes

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global New-Born Screening Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 New-Born Screening Outlook to 2028- Original Forecasts

    • 2.2 New-Born Screening Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term New-Born Screening Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global New-Born Screening Market- Recent Developments

    • 6.1 New-Born Screening Market News and Developments

    • 6.2 New-Born Screening Market Deals Landscape

    7 New-Born Screening Raw Materials and Cost Structure Analysis

    • 7.1 New-Born Screening Key Raw Materials

    • 7.2 New-Born Screening Price Trend of Key Raw Materials

    • 7.3 New-Born Screening Key Suppliers of Raw Materials

    • 7.4 New-Born Screening Market Concentration Rate of Raw Materials

    • 7.5 New-Born Screening Cost Structure Analysis

      • 7.5.1 New-Born Screening Raw Materials Analysis

      • 7.5.2 New-Born Screening Labor Cost Analysis

      • 7.5.3 New-Born Screening Manufacturing Expenses Analysis

    8 Global New-Born Screening Import and Export Analysis (Top 10 Countries)

    • 8.1 Global New-Born Screening Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global New-Born Screening Export by Region (Top 10 Countries) (2017-2028)

    9 Global New-Born Screening Market Outlook by Types and Applications to 2022

    • 9.1 Global New-Born Screening Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tandem Mass Spectrometry Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pulse Oximetry Screening Technology Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global DNA-Based Assays Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hearing Screen Technology Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global New-Born Screening Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Nursing Homes Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise New-Born Screening Market Analysis and Outlook till 2022

    • 10.1 Global New-Born Screening Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States New-Born Screening Consumption (2017-2022)

      • 10.2.2 Canada New-Born Screening Consumption (2017-2022)

      • 10.2.3 Mexico New-Born Screening Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany New-Born Screening Consumption (2017-2022)

      • 10.3.2 UK New-Born Screening Consumption (2017-2022)

      • 10.3.3 Spain New-Born Screening Consumption (2017-2022)

      • 10.3.4 Belgium New-Born Screening Consumption (2017-2022)

      • 10.3.5 France New-Born Screening Consumption (2017-2022)

      • 10.3.6 Italy New-Born Screening Consumption (2017-2022)

      • 10.3.7 Denmark New-Born Screening Consumption (2017-2022)

      • 10.3.8 Finland New-Born Screening Consumption (2017-2022)

      • 10.3.9 Norway New-Born Screening Consumption (2017-2022)

      • 10.3.10 Sweden New-Born Screening Consumption (2017-2022)

      • 10.3.11 Poland New-Born Screening Consumption (2017-2022)

      • 10.3.12 Russia New-Born Screening Consumption (2017-2022)

      • 10.3.13 Turkey New-Born Screening Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China New-Born Screening Consumption (2017-2022)

      • 10.4.2 Japan New-Born Screening Consumption (2017-2022)

      • 10.4.3 India New-Born Screening Consumption (2017-2022)

      • 10.4.4 South Korea New-Born Screening Consumption (2017-2022)

      • 10.4.5 Pakistan New-Born Screening Consumption (2017-2022)

      • 10.4.6 Bangladesh New-Born Screening Consumption (2017-2022)

      • 10.4.7 Indonesia New-Born Screening Consumption (2017-2022)

      • 10.4.8 Thailand New-Born Screening Consumption (2017-2022)

      • 10.4.9 Singapore New-Born Screening Consumption (2017-2022)

      • 10.4.10 Malaysia New-Born Screening Consumption (2017-2022)

      • 10.4.11 Philippines New-Born Screening Consumption (2017-2022)

      • 10.4.12 Vietnam New-Born Screening Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil New-Born Screening Consumption (2017-2022)

      • 10.5.2 Colombia New-Born Screening Consumption (2017-2022)

      • 10.5.3 Chile New-Born Screening Consumption (2017-2022)

      • 10.5.4 Argentina New-Born Screening Consumption (2017-2022)

      • 10.5.5 Venezuela New-Born Screening Consumption (2017-2022)

      • 10.5.6 Peru New-Born Screening Consumption (2017-2022)

      • 10.5.7 Puerto Rico New-Born Screening Consumption (2017-2022)

      • 10.5.8 Ecuador New-Born Screening Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain New-Born Screening Consumption (2017-2022)

      • 10.6.2 Kuwait New-Born Screening Consumption (2017-2022)

      • 10.6.3 Oman New-Born Screening Consumption (2017-2022)

      • 10.6.4 Qatar New-Born Screening Consumption (2017-2022)

      • 10.6.5 Saudi Arabia New-Born Screening Consumption (2017-2022)

      • 10.6.6 United Arab Emirates New-Born Screening Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria New-Born Screening Consumption (2017-2022)

      • 10.7.2 South Africa New-Born Screening Consumption (2017-2022)

      • 10.7.3 Egypt New-Born Screening Consumption (2017-2022)

      • 10.7.4 Algeria New-Born Screening Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia New-Born Screening Consumption (2017-2022)

      • 10.8.2 New Zealand New-Born Screening Consumption (2017-2022)

    11 Global New-Born Screening Competitive Analysis

    • 11.1 Waters

      • 11.1.1 Waters Company Details

      • 11.1.2 Waters New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Waters New-Born Screening Main Business and Markets Served

      • 11.1.4 Waters New-Born Screening Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Natus Medical

      • 11.2.1 Natus Medical Company Details

      • 11.2.2 Natus Medical New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Natus Medical New-Born Screening Main Business and Markets Served

      • 11.2.4 Natus Medical New-Born Screening Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bio-Rad Laboratories

      • 11.3.1 Bio-Rad Laboratories Company Details

      • 11.3.2 Bio-Rad Laboratories New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bio-Rad Laboratories New-Born Screening Main Business and Markets Served

      • 11.3.4 Bio-Rad Laboratories New-Born Screening Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Trivitron Healthcare

      • 11.4.1 Trivitron Healthcare Company Details

      • 11.4.2 Trivitron Healthcare New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Trivitron Healthcare New-Born Screening Main Business and Markets Served

      • 11.4.4 Trivitron Healthcare New-Born Screening Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Perkinelmer

      • 11.5.1 Perkinelmer Company Details

      • 11.5.2 Perkinelmer New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Perkinelmer New-Born Screening Main Business and Markets Served

      • 11.5.4 Perkinelmer New-Born Screening Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 AB Sciex

      • 11.6.1 AB Sciex Company Details

      • 11.6.2 AB Sciex New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 AB Sciex New-Born Screening Main Business and Markets Served

      • 11.6.4 AB Sciex New-Born Screening Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 GE Healthcare

      • 11.7.1 GE Healthcare Company Details

      • 11.7.2 GE Healthcare New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 GE Healthcare New-Born Screening Main Business and Markets Served

      • 11.7.4 GE Healthcare New-Born Screening Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Covidien

      • 11.8.1 Covidien Company Details

      • 11.8.2 Covidien New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Covidien New-Born Screening Main Business and Markets Served

      • 11.8.4 Covidien New-Born Screening Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Masimo

      • 11.9.1 Masimo Company Details

      • 11.9.2 Masimo New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Masimo New-Born Screening Main Business and Markets Served

      • 11.9.4 Masimo New-Born Screening Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Agilent Technologies

      • 11.10.1 Agilent Technologies Company Details

      • 11.10.2 Agilent Technologies New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Agilent Technologies New-Born Screening Main Business and Markets Served

      • 11.10.4 Agilent Technologies New-Born Screening Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global New-Born Screening Market Outlook by Types and Applications to 2028

    • 12.1 Global New-Born Screening Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Tandem Mass Spectrometry Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Pulse Oximetry Screening Technology Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global DNA-Based Assays Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Hearing Screen Technology Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global New-Born Screening Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Nursing Homes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise New-Born Screening Market Analysis and Outlook to 2028

    • 13.1 Global New-Born Screening Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States New-Born Screening Consumption Forecast (2022-2028)

      • 13.2.2 Canada New-Born Screening Consumption Forecast (2022-2028)

      • 13.2.3 Mexico New-Born Screening Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.2 UK New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.3 Spain New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.4 Belgium New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.5 France New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.6 Italy New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.7 Denmark New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.8 Finland New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.9 Norway New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.10 Sweden New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.11 Poland New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.12 Russia New-Born Screening Consumption Forecast (2022-2028)

      • 13.3.13 Turkey New-Born Screening Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.2 Japan New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.3 India New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.4 South Korea New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.8 Thailand New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.9 Singapore New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.11 Philippines New-Born Screening Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam New-Born Screening Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil New-Born Screening Consumption Forecast (2022-2028)

      • 13.5.2 Colombia New-Born Screening Consumption Forecast (2022-2028)

      • 13.5.3 Chile New-Born Screening Consumption Forecast (2022-2028)

      • 13.5.4 Argentina New-Born Screening Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela New-Born Screening Consumption Forecast (2022-2028)

      • 13.5.6 Peru New-Born Screening Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico New-Born Screening Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador New-Born Screening Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain New-Born Screening Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait New-Born Screening Consumption Forecast (2022-2028)

      • 13.6.3 Oman New-Born Screening Consumption Forecast (2022-2028)

      • 13.6.4 Qatar New-Born Screening Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia New-Born Screening Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates New-Born Screening Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria New-Born Screening Consumption Forecast (2022-2028)

      • 13.7.2 South Africa New-Born Screening Consumption Forecast (2022-2028)

      • 13.7.3 Egypt New-Born Screening Consumption Forecast (2022-2028)

      • 13.7.4 Algeria New-Born Screening Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia New-Born Screening Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand New-Born Screening Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of New-Born Screening

    • Figure of New-Born Screening Picture

    • Table Global New-Born Screening Import by Region (Top 10 Countries) (2017-2028)

    • Table Global New-Born Screening Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Tandem Mass Spectrometry Consumption and Growth Rate (2017-2022)

    • Figure Global Pulse Oximetry Screening Technology Consumption and Growth Rate (2017-2022)

    • Figure Global DNA-Based Assays Consumption and Growth Rate (2017-2022)

    • Figure Global Hearing Screen Technology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Nursing Homes Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global New-Born Screening Consumption by Country (2017-2022)

    • Table North America New-Born Screening Consumption by Country (2017-2022)

    • Figure United States New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Canada New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Mexico New-Born Screening Consumption and Growth Rate (2017-2022)

    • Table Europe New-Born Screening Consumption by Country (2017-2022)

    • Figure Germany New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure UK New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Spain New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Belgium New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure France New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Italy New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Denmark New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Finland New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Norway New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Sweden New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Poland New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Russia New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Turkey New-Born Screening Consumption and Growth Rate (2017-2022)

    • Table APAC New-Born Screening Consumption by Country (2017-2022)

    • Figure China New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Japan New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure India New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure South Korea New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Pakistan New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Indonesia New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Thailand New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Singapore New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Malaysia New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Philippines New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Vietnam New-Born Screening Consumption and Growth Rate (2017-2022)

    • Table South America New-Born Screening Consumption by Country (2017-2022)

    • Figure Brazil New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Colombia New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Chile New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Argentina New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Venezuela New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Peru New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Ecuador New-Born Screening Consumption and Growth Rate (2017-2022)

    • Table GCC New-Born Screening Consumption by Country (2017-2022)

    • Figure Bahrain New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Kuwait New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Oman New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Qatar New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates New-Born Screening Consumption and Growth Rate (2017-2022)

    • Table Africa New-Born Screening Consumption by Country (2017-2022)

    • Figure Nigeria New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure South Africa New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Egypt New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure Algeria New-Born Screening Consumption and Growth Rate (2017-2022)

    • Table Oceania New-Born Screening Consumption by Country (2017-2022)

    • Figure Australia New-Born Screening Consumption and Growth Rate (2017-2022)

    • Figure New Zealand New-Born Screening Consumption and Growth Rate (2017-2022)

    • Table Waters Company Details

    • Table Waters New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Waters New-Born Screening Main Business and Markets Served

    • Table Waters New-Born Screening Product Portfolio

    • Table Natus Medical Company Details

    • Table Natus Medical New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Natus Medical New-Born Screening Main Business and Markets Served

    • Table Natus Medical New-Born Screening Product Portfolio

    • Table Bio-Rad Laboratories Company Details

    • Table Bio-Rad Laboratories New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories New-Born Screening Main Business and Markets Served

    • Table Bio-Rad Laboratories New-Born Screening Product Portfolio

    • Table Trivitron Healthcare Company Details

    • Table Trivitron Healthcare New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Trivitron Healthcare New-Born Screening Main Business and Markets Served

    • Table Trivitron Healthcare New-Born Screening Product Portfolio

    • Table Perkinelmer Company Details

    • Table Perkinelmer New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Perkinelmer New-Born Screening Main Business and Markets Served

    • Table Perkinelmer New-Born Screening Product Portfolio

    • Table AB Sciex Company Details

    • Table AB Sciex New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB Sciex New-Born Screening Main Business and Markets Served

    • Table AB Sciex New-Born Screening Product Portfolio

    • Table GE Healthcare Company Details

    • Table GE Healthcare New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare New-Born Screening Main Business and Markets Served

    • Table GE Healthcare New-Born Screening Product Portfolio

    • Table Covidien Company Details

    • Table Covidien New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Covidien New-Born Screening Main Business and Markets Served

    • Table Covidien New-Born Screening Product Portfolio

    • Table Masimo Company Details

    • Table Masimo New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Masimo New-Born Screening Main Business and Markets Served

    • Table Masimo New-Born Screening Product Portfolio

    • Table Agilent Technologies Company Details

    • Table Agilent Technologies New-Born Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies New-Born Screening Main Business and Markets Served

    • Table Agilent Technologies New-Born Screening Product Portfolio

    • Figure Global Tandem Mass Spectrometry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulse Oximetry Screening Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DNA-Based Assays Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hearing Screen Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nursing Homes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global New-Born Screening Consumption Forecast by Country (2022-2028)

    • Table North America New-Born Screening Consumption Forecast by Country (2022-2028)

    • Figure United States New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe New-Born Screening Consumption Forecast by Country (2022-2028)

    • Figure Germany New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure France New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC New-Born Screening Consumption Forecast by Country (2022-2028)

    • Figure China New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure India New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table South America New-Born Screening Consumption Forecast by Country (2022-2028)

    • Figure Brazil New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC New-Born Screening Consumption Forecast by Country (2022-2028)

    • Figure Bahrain New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa New-Born Screening Consumption Forecast by Country (2022-2028)

    • Figure Nigeria New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania New-Born Screening Consumption Forecast by Country (2022-2028)

    • Figure Australia New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand New-Born Screening Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.